Earnings summaries and quarterly performance for CALLAN JMB.
Research analysts covering CALLAN JMB.
Recent press releases and 8-K filings for CJMB.
Callan JMB Announces Q3 2025 Financial Results and Business Updates
CJMB
Earnings
New Projects/Investments
Revenue Acceleration/Inflection
- Callan JMB Inc. reported revenues of $1.4 million for the third quarter ended September 30, 2025, and a net loss of ($2.7 million), resulting in a net loss per common share of ($0.61) for the quarter.
- The company expanded its compliance-driven logistics platform into the food sampling industry and entered an agreement to install oral drug delivery equipment at its Texas facility.
- Callan JMB established a subsidiary in India with plans for a temperature-controlled pharmaceutical storage and distribution warehouse.
- The contract with the City of Chicago was extended through June 2026, with an additional $1.5 million in funding, bringing the total contract value to $9.1 million.
- As of September 30, 2025, cash and cash equivalents were $2.8 million.
Nov 14, 2025, 9:06 PM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more